1. Guo J#, Li C#, Fang Q, Liu Y, Wang D, Chen Y, Xie W*, Zhang Y*.The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1.J Exp Clin Cancer Res.2022.41(1).26.SCI |
2. Weiyan Xie#, Qiuyue Fang#, Jing Guo, Lei Gong, Chuzhong Li, Yazhuo Zhang* .Phosphorylation of Pit-1 by cyclin-dependent kinase 5 at serine 126 is associated with cell proliferation and poor prognosis in prolactinomas.Open Chemistry.2021.19 (1).785-793.SCI |
3. Li C#, Xie W#, Rosenblum JS, Zhou J, Guo J, Miao Y, Shen Y, Wang H, Gong L, Li M, Zhao S, Cheng S, Zhu H, Jiang T, Ling S, Wang F, Zhang H, Zhang M, Qu Y, Zhang Q, Li G, Wang J, Ma J, Zhuang Z, Zhang Y*.Somatic SF3B1 hotspot mutation in prolactinomas.Nature Communications.2020.11 (1).2506.SCI |
4. Miao Y, Li C, Guo J, Wang H, Gong L, Xie W*, Zhang Y*.Identification of a novel somatic mutation of POU6F2 by whole-genome sequencing in prolactinoma.Mol Genet Genomic Med.2019.7 (12).e1022.SCI |
5. Xie W#, Liu C#, Wu D, Li Z, Li C, Zhang Y*.Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas.Oncotarget.2016.7(32).50883-50894.EI |
6. Liu C#, Xie W#, Wu D, Li Z, Li C, Zhang Y*.Expression of cell-cycle regulators is associated with invasive behavior and poor prognosis in prolactinomas.Int J Clin Exp Pathol.2016.9(3).3245-3255.SCI |
7. Xie W, Wang H, He Y, Li D, Gong L, Zhang Y* .CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression.Int J Biol Sci.2014.10(2).192-199.SCI |
8. Chen H#, Xie W#, Hu F, Zhang Y, Wang J, Wang Y* .Disruption of δ-opioid receptor phosphorylation at threonine 161 attenuates morphine tolerance in rats with CFA-induced inflammatory hypersensitivity.Neurosci Bull.2012.28(2).182-192 .SCI |
9. Xie W#, He Y#, Yang Y, Li Y, Kang K, Xing B, Wang Y*.Disruption of Cdk5-Associated Phosphorylation of Residue Threonine-161 of the Delta Opioid Receptor: Impaired Receptor Function and Attenuated Morphine Antinociceptive Tolerance.J Neurosci.2009.29(11).3551-3564 .SCI |